Dendreon's Positive Panel Surprise (The Motley Fool)
Shares of Dendreon jump after a FDA advisory panel finds in favor of its lead drug.

Tactic to compel FDA review gives Pharmacyclics boost (San Francisco Chronicle)
Shares in Pharmacyclics Inc. rose 14 percent Thursday after the Sunnyvale biotechnology company said it will try to win approval of its experimental cancer drug through a regulatory tactic that analysts say is the equivalent of a Hail Mary pass....